Michael A. Rapp mainly focuses on Cognition, Alzheimer's disease, Prefrontal cortex, Depression and Functional magnetic resonance imaging. His research integrates issues of Developmental psychology and Clinical psychology in his study of Cognition. His Alzheimer's disease research is multidisciplinary, relying on both Randomized controlled trial and Dementia.
His Prefrontal cortex research is multidisciplinary, incorporating perspectives in Schizophrenia, Psychosis, Addiction and Ventral striatum. Depression is a subfield of Psychiatry that Michael A. Rapp tackles. His Functional magnetic resonance imaging study combines topics in areas such as Alcohol dependence, Cognitive psychology and Audiology.
Psychiatry, Dementia, Depression, Cognition and Clinical psychology are his primary areas of study. His research on Dementia also deals with topics like
His biological study deals with issues like Developmental psychology, which deal with fields such as Executive functions. In his research on the topic of Prefrontal cortex, Alcohol dependence is strongly related with Ventral striatum. His studies deal with areas such as Cognitive psychology, Functional magnetic resonance imaging and Audiology as well as Working memory.
Michael A. Rapp mainly investigates Clinical psychology, Cognition, Gynecology, German and Depression. His Clinical psychology research incorporates themes from Alcohol dependence, Alcohol Use Disorders Identification Test, Clinical significance, Substance abuse and Punishment. His Effects of sleep deprivation on cognitive performance and Priming study, which is part of a larger body of work in Cognition, is frequently linked to Music psychology, bridging the gap between disciplines.
His Effects of sleep deprivation on cognitive performance study combines topics from a wide range of disciplines, such as Working memory, Social stress and Elementary cognitive task. His Depression research includes elements of Homeostasis, Anxiety, Monetary incentive delay task, Reward sensitivity and Risk factor. His study on Psychosomatic medicine is covered under Psychiatry.
His primary areas of investigation include Randomized controlled trial, Psychological intervention, Mental health, Clinical psychology and Meta-analysis. The study incorporates disciplines such as Nursing, Dementia and Empowerment in addition to Randomized controlled trial. His studies examine the connections between Dementia and genetics, as well as such issues in Coping, with regards to Quality of life.
His Mental health research is within the category of Psychiatry. The Clinical psychology study combines topics in areas such as Schizophrenia and Risk factor. Michael A. Rapp has included themes like Physical therapy, Depression and Anxiety in his Meta-analysis study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression
Michael A. Rapp;Michal Schnaider-Beeri;Hillel T. Grossman;Mary Sano.
Archives of General Psychiatry (2006)
Cities and Mental Health.
Oliver Gruebner;Michael A. Rapp;Mazda Adli;Ulrike Kluge.
Deutsches Arzteblatt International (2017)
Neuropsychological differences between late-onset and recurrent geriatric major depression.
Michael A. Rapp;Karen Dahlman;Mary Sano;Hillel T. Grossman.
American Journal of Psychiatry (2005)
Attention and executive control predict Alzheimer disease in late life: Results from the Berlin Aging Study (BASE)
Michael A. Rapp;Michael A. Rapp;Friedel M. Reischies.
American Journal of Geriatric Psychiatry (2005)
Striatal dysfunction during reversal learning in unmedicated schizophrenia patients
Florian Schlagenhauf;Quentin J. M. Huys;Lorenz Deserno;Michael A. Rapp.
NeuroImage (2014)
Animal-Assisted Therapy and Agitation and Depression in Nursing Home Residents with Dementia: A Matched Case–Control Trial
Tomislav Majic;Hans Gutzmann;Andreas Heinz;Undine E. Lang.
American Journal of Geriatric Psychiatry (2013)
Elaboration on Premorbid Intellectual Performance in Schizophrenia Premorbid Intellectual Decline and Risk for Schizophrenia
Abraham Reichenberg;Mark Weiser;Michael A. Rapp;Jonathan Rabinowitz.
Archives of General Psychiatry (2005)
Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions.
Florian Schlagenhauf;Philipp Sterzer;Katharina Schmack;Martina Ballmaier.
Biological Psychiatry (2009)
Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
Andreas Ströhle;Dietlinde K. Schmidt;Florian Schultz;Nina Fricke.
American Journal of Geriatric Psychiatry (2015)
Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders
Claudia Hägele;Florian Schlagenhauf;Florian Schlagenhauf;Michael Rapp;Philipp Sterzer.
Psychopharmacology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Charité - University Medicine Berlin
Charité - University Medicine Berlin
University College London
TU Dresden
Max Planck Society
Charité - University Medicine Berlin
Humboldt-Universität zu Berlin
Heidelberg University
Heidelberg University
Massachusetts General Hospital
Swinburne University of Technology
Otto-von-Guericke University Magdeburg
Texas Instruments (United States)
Shanghai Jiao Tong University
Harbin Institute of Technology
Bielefeld University
Children's Hospital of Philadelphia
University of Tübingen
University of Lausanne
University of Crete
United States Department of Veterans Affairs
National Autonomous University of Mexico
University of Birmingham
Technical University of Munich
University of Queensland
University of Pennsylvania